| 1 |
NNOX
|
ai
cloud
healthcare
medical devices
software
|
Nano-X Imaging Ltd.
|
8.0x
|
0.40
|
Nanox is a distressed but real option on turning FDA-cleared low-cost imaging hardware plus AI, teleradiology, and Health IT into a managed imaging utility; if financing and activation gates clear, a tiny revenue base can compound non-linearly as each live site carries multiple attached revenue streams.
|
| 2 |
HURA
|
biotech
healthcare
|
TuHURA Biosciences, Inc.
|
5.4x
|
0.30
|
TuHURA is a survival-to-scale rare-oncology bet: if IFx-2.0 clears Phase 3 and management uses ex-US partnering to reduce dilution, the company can rerate from distressed optionality to a focused orphan-commercial and licensing story by 2031.
|
| 3 |
AISP
|
ai
defense
enterprise
hardware
software
|
Airship AI Holdings, Inc.
|
4.7x
|
0.44
|
Airship AI has a credible path from a tiny, lumpy contractor into a trusted edge-to-evidence workflow vendor if it converts federal pipeline into deployments, then attaches higher-value verification, support, and partner-led distribution; the upside is trust and workflow embedment, not generic model ownership.
|
| 4 |
DNA
|
ai
automation
biotech
healthcare
software
|
Ginkgo Bioworks Holdings, Inc.
|
4.6x
|
0.40
|
Ginkgo is a leveraged option on manual biology moving into autonomous, AI-linked lab execution; if it converts Nebula capacity, broader protocols, and customer-site deployments into repeat paid throughput before capital tightens, revenue can compound severalfold and the equity can rerate from project-shop skepticism toward infrastructure status.
|
| 5 |
NTLA
|
ai
biotech
healthcare
|
Intellia Therapeutics, Inc.
|
4.6x
|
0.45
|
If lonvo-z clears FDA and launches well, Intellia can shift from a collaboration-funded platform to a real rare-disease gene-editing franchise with reusable clinical, payer and treatment-center infrastructure; that approval-to-commercial conversion creates a realistic path to multi-bagger equity value by 2031.
|
| 6 |
RR
|
ai
automation
enterprise
hardware
robotics
|
Richtech Robotics Inc.
|
4.4x
|
0.40
|
Richtech is a cash-backed option on service robotics adoption: if it converts tiny current revenue into dense multi-site recurring deployments and workflow-embedded contracts, equity value can compound meaningfully from a small base; if not, it remains a promotional, subscale robot vendor with weak bargaining power.
|
| 7 |
RXRX
|
ai
automation
biotech
healthcare
software
|
Recursion Pharmaceuticals, Inc.
|
4.4x
|
0.55
|
Recursion is a proof-gated AI biotech where the upside comes from turning proprietary data, automated labs, and owned assets into repeatable clinical wins; if REC-4881 gains a workable registrational path and one more internal program validates translation, revenue mix can shift from lumpy collaborations toward higher-value products, milestones, and royalties by 2031.
|
| 8 |
APUS
|
ai
biotech
crypto
finance
healthcare
|
Apimeds Pharmaceuticals US, Inc.
|
4.2x
|
0.12
|
APUS is a distressed option on sequencing four wins: cure listing and forbearance issues, secure durable capital, separate the biotech and treasury stories cleanly, and monetize Apitox through partners while MindWave proves trust-heavy treasury workflows. If those gates clear, the stock can rerate from shell-like pricing, but the upside comes from survival and deal quality more than from owning an AI choke point.
|
| 9 |
ACHR
|
aerospace
automation
defense
evtol
transportation
|
Archer Aviation Inc.
|
4.0x
|
0.45
|
Archer can rerate from a pre-commercial aircraft developer into a regulated mobility platform if 2026 certification and first operations unlock repeatable city launches, while defense, training, dispatch, and compliance workflows add recurring economics on top of aircraft sales.
|
| 10 |
SERV
|
ai
automation
healthcare
robotics
transportation
|
Serve Robotics Inc.
|
3.7x
|
0.60
|
Serve can still compound meaningfully if it turns a large installed robot base and new hospital footprint into dense recurring revenue per operating hour; the real upside is not more robots alone, but better utilization, workflow embedment, and higher-value software/trust layers on top of physical operations.
|
| 11 |
PRME
|
biotech
healthcare
|
Prime Medicine, Inc.
|
3.6x
|
0.20
|
Prime Medicine is a financing-constrained option on platform validation: if PM577 and PM647 reach the clinic on time, AATD rights are preserved, and capital is raised on tolerable terms, the company can shift from cash-box optionality to a repeatable liver-franchise story by 2031; if not, dilution absorbs much of the scientific upside.
|
| 12 |
SDGR
|
ai
biotech
cloud
healthcare
software
|
Schrödinger, Inc.
|
3.6x
|
0.56
|
The 5-year upside is a workflow-quality upgrade, not a heroic biotech bet: if hosted delivery, LiveDesign, and Bunsen turn Schrödinger into a governed discovery operating layer, it can capture more throughput and trust value per account while partnered drug economics preserve upside without forcing a balance-sheet-heavy pipeline build.
|
| 13 |
BEAM
|
biotech
healthcare
|
Beam Therapeutics Inc.
|
3.4x
|
0.40
|
Beam can rerate from cash-backed platform optionality to a two-franchise gene-editing company if risto-cel reaches market on time and BEAM-302 converts early in vivo proof into an accelerated-approval package; the upside comes from reusing delivery, manufacturing, and regulatory learning across rare-disease programs and selective platform deals.
|
| 14 |
QUBT
|
ai
cybersecurity
hardware
quantum
semiconductors
|
Quantum Computing Inc.
|
3.4x
|
0.45
|
QCi’s best 5-year path is not winning general quantum computing; it is becoming a scarce U.S. photonics process, packaging, and trust supplier with attached security and edge-compute products. If it converts Fab 1 know-how, acquisitions, and backlog into repeat orders, revenue can inflect sharply, but today’s valuation already prices in meaningful success, so upside is more likely 2-5x than 10x+.
|
| 15 |
AI
|
ai
automation
defense
enterprise
software
|
C3.ai, Inc.
|
3.2x
|
0.40
|
C3 AI is a low-EV turnaround option on governed enterprise AI: if it converts proofs into repeatable production, attaches trust and compliance layers to regulated workflows, and scales through partners, revenue can reach 1000 by 2031 and support a roughly 2x equity outcome without needing frontier-model leadership.
|
| 16 |
MSTR
|
ai
crypto
enterprise
finance
software
|
Strategy Inc
|
3.2x
|
0.40
|
Over the next five years, Strategy can still roughly triple enterprise value if it preserves a financing premium over bitcoin value, keeps growing bitcoin per common-share faster than senior claims, and turns its software into a verification layer for agentic finance workflows; the upside is real, but the gate is capital-markets absorption, not software seats.
|
| 17 |
MBLY
|
ai
automation
automotive
semiconductors
software
|
Mobileye Global Inc.
|
3.1x
|
0.60
|
Mobileye can grow from a scaled ADAS chip supplier into a higher-value automotive trust layer for advanced driving if EyeQ6-era launches convert on time; the equity case is driven by mix shift, validation credibility, and a modest rerating rather than heroic robotaxi volume.
|
| 18 |
PDYN
|
aerospace
ai
automation
defense
software
|
Palladyne AI Corp.
|
3.1x
|
0.40
|
Palladyne can grow from a very small base into a real defense-autonomy supplier if 2026 backlog conversion turns into repeat programs and the company lifts software, assurance, and partner-channel mix faster than burn and dilution rise; the upside is real, but it only works if procurement proof arrives before primes internalize the autonomy layer.
|
| 19 |
INOD
|
ai
cloud
enterprise
software
|
Innodata Inc.
|
3.0x
|
0.40
|
Innodata can grow from a fast-ramping AI data-engineering vendor into a recurring AI assurance and governed-workflow supplier if it converts hyperscaler relationships into diversified, embedded control-layer revenue before customers internalize too much of the stack.
|
| 20 |
QBTS
|
ai
cloud
hardware
quantum
software
|
D-Wave Quantum Inc.
|
2.9x
|
0.48
|
D-Wave’s best 5-year path is not selling isolated quantum experiments but becoming a recurring optimization engine across enterprise, government, and embedded software workflows; if bookings convert, systems install on time, and the dual-platform roadmap holds, revenue can scale fast enough to outrun dilution, though not enough to preserve today’s concept-stock multiple.
|
| 21 |
SPIR
|
aerospace
communications
defense
software
space
|
Spire Global, Inc.
|
2.9x
|
0.60
|
Spire can turn a hard-to-replicate satellite and data stack into a higher-quality defense, weather, aviation, and sovereign intelligence franchise; if 2026-2027 proves contract conversion and self-funded operations, revenue can scale much faster than the fixed asset base.
|
| 22 |
CRSP
|
biotech
healthcare
|
CRISPR Therapeutics AG
|
2.9x
|
0.46
|
CRISPR Therapeutics has already cleared the credibility hurdle with the first approved CRISPR therapy; the five-year upside now comes from turning that proof point into a second real franchise, most plausibly liver editing or zugo-cel, while using its balance sheet and manufacturing know-how to keep more downstream economics.
|
| 23 |
S
|
ai
cloud
cybersecurity
enterprise
software
|
SentinelOne, Inc.
|
2.7x
|
0.55
|
SentinelOne can roughly 2.5x enterprise value by 2031 if it keeps turning endpoint footholds into broader cloud, identity, data, and AI-security spend, using workflow embeddedness, telemetry, and regulated-deployment trust to monetize automation as a control layer rather than just a detection product.
|
| 24 |
ESTC
|
ai
cloud
cybersecurity
enterprise
software
|
Elastic N.V.
|
2.7x
|
0.56
|
Elastic is a discounted AI-era data and trust layer: if it turns rising machine data, security telemetry, and agentic retrieval into governed paid usage across cloud, serverless, and regulated deployments, revenue can roughly double by 2031 and the stock can compound near the bull case without requiring a return to peak software multiples.
|
| 25 |
IREN
|
ai
cloud
crypto
energy
hardware
|
IREN Limited
|
2.7x
|
0.74
|
IREN can still compound by converting scarce, power-connected campuses into contracted AI infrastructure faster than dilution and depreciation erode per-share value; the upside is nonlinear if it becomes a repeatable allocator and operator of powered compute, not just a miner with a cloud add-on.
|
| 26 |
TEM
|
ai
biotech
enterprise
healthcare
software
|
Tempus AI, Inc.
|
2.7x
|
0.60
|
Tempus can still compound into a much larger healthcare data-and-workflow company if it keeps converting each diagnostic interaction into higher-margin data, modeling, and embedded clinical workflow revenue; the upside is real, but it depends more on economic conversion than on AI narrative alone.
|
| 27 |
AUR
|
ai
automation
robotics
software
transportation
|
Aurora Innovation, Inc.
|
2.7x
|
0.65
|
Aurora can turn early driverless freight proof into a valuable control point if it converts lane validation, safety trust, and OEM integration into contracted recurring capacity before partner bargaining power and dilution absorb the economics.
|
| 28 |
JOBY
|
aerospace
ai
automation
evtol
transportation
|
Joby Aviation, Inc.
|
2.7x
|
0.60
|
If Joby turns its certification lead into dense premium corridor operations, aircraft placements, and recurring fleet-service contracts, it can evolve from a pre-scale aircraft story into a regulated mobility network with meaningful 5-year equity upside, though the upside still depends on converting approvals into utilization rather than just headlines.
|
| 29 |
RCAT
|
aerospace
automation
defense
hardware
robotics
|
Red Cat Holdings, Inc.
|
2.7x
|
0.60
|
Red Cat’s five-year upside comes from turning compliance-led drone demand into a broader Western small-systems franchise: common control, repeat allied orders, maritime expansion, and readiness-style contracts can push it beyond one-program hardware status if current inventory and cash convert into durable revenue and margin proof.
|
| 30 |
RDVT
|
ai
cloud
enterprise
finance
software
|
Red Violet, Inc.
|
2.7x
|
0.60
|
RDVT is a profitable identity-intelligence utility that should benefit as AI agents and digital workflows create more verification, fraud, and due-diligence events; if it keeps embedding CORE deeper into customer workflows and adds higher-value monitoring and trust products, revenue can plausibly reach 300 by 2031 without needing extreme share gains.
|
| 31 |
ZS
|
ai
cloud
cybersecurity
enterprise
software
|
Zscaler, Inc.
|
2.7x
|
0.60
|
Zscaler already controls an inline enterprise trust gate that should become more valuable as AI expands traffic, machine identities, data egress, and sovereignty needs; if it keeps shifting monetization from seats toward usage, data, and agent governance, revenue can more than double by 2031 even without regaining its old peak multiple.
|
| 32 |
LMND
|
ai
automation
finance
software
|
Lemonade, Inc.
|
2.7x
|
0.40
|
Lemonade can grow into a meaningfully larger, self-funding personal-lines insurer by 2031 if its AI-led underwriting, claims automation, car expansion, and multi-policy household strategy keep improving loss costs and acquisition efficiency inside regulated carrier balance sheets.
|
| 33 |
SMR
|
energy
hardware
nuclear
|
NuScale Power Corporation
|
2.6x
|
0.60
|
NuScale is a leveraged bet that AI-era power scarcity turns a rare U.S. nuclear licensing lead into bankable first projects; if one anchor U.S. deal and continued Romania progress convert, revenue can jump from de minimis services to meaningful module, services, and lifecycle capture by 2031.
|
| 34 |
OUST
|
ai
automation
hardware
robotics
software
|
Ouster, Inc.
|
2.6x
|
0.61
|
Ouster is a credible physical-AI picks-and-shovels name: if Rev8 and Stereolabs turn it into a qualified sensing-and-perception stack rather than a stand-alone lidar vendor, revenue can compound rapidly even as hardware multiples compress.
|
| 35 |
POET
|
ai
hardware
networking
semiconductors
|
POET Technologies Inc.
|
2.6x
|
0.63
|
POET sits in a real AI optics bottleneck, and the May 2026 capital raise gives it enough runway to chase a non-linear jump from qualification-stage revenue to meaningful production revenue; the stock outcome now depends less on survival and more on whether Malaysia scale-up and partner programs convert into repeat backlog before larger vendors absorb the economics.
|
| 36 |
PATH
|
ai
automation
cloud
enterprise
software
|
UiPath, Inc.
|
2.5x
|
0.50
|
UiPath can roughly double revenue over five years if it becomes the governed execution layer for agents, robots, documents, and people inside large enterprises; the equity upside comes from monetizing orchestration, trust, testing, and vertical workflows faster than bundle pressure erodes legacy seat economics.
|
| 37 |
RLAY
|
ai
biotech
healthcare
|
Relay Therapeutics, Inc.
|
2.5x
|
0.40
|
Relay is a leveraged bet that zovegalisib becomes a differentiated PI3K-alpha franchise across metastatic breast cancer and vascular anomalies; AI-enabled discovery helps create the asset, but five-year value still turns on clinical replication, regulatory execution and disciplined financing.
|
| 38 |
COIN
|
crypto
enterprise
finance
software
|
Coinbase Global, Inc.
|
2.5x
|
0.60
|
Coinbase can compound from a cyclical crypto broker into a regulated onchain financial utility if stablecoin, derivatives, custody, and developer rails scale faster than spot-fee cyclicality and fee compression.
|
| 39 |
FLNC
|
automation
energy
enterprise
software
|
Fluence Energy, Inc.
|
2.5x
|
0.63
|
Fluence can compound by keeping roughly similar share in a much larger storage market while converting backlog, hyperscaler access, and installed-base service software attach into a cleaner operating model; the upside comes from better value capture around projects, not from owning battery cells.
|
| 40 |
NOW
|
ai
automation
cloud
enterprise
software
|
ServiceNow, Inc.
|
2.5x
|
0.68
|
ServiceNow can outgrow mature software peers if it turns its installed workflow base into the trusted execution, governance, and evidence rail for AI agents, shifting value capture from human seats toward verified actions, security, and outcome-linked automation.
|
| 41 |
NBIS
|
ai
cloud
enterprise
software
|
Nebius Group N.V.
|
2.5x
|
0.64
|
Nebius can still create strong equity value by 2031 if it converts scarce contracted power into active, highly utilized AI cloud capacity and layers higher-value inference, sovereign-region and trust software on top; demand is real, so the swing factor is execution and financing discipline rather than customer discovery.
|
| 42 |
BFLY
|
ai
enterprise
healthcare
medical devices
software
|
Butterfly Network, Inc.
|
2.5x
|
0.56
|
Butterfly has a credible 5-year path from a handheld-ultrasound vendor to a higher-quality imaging platform if it converts iQ3 adoption, enterprise workflow, home/community care, and Embedded into repeatable recurring revenue before incumbents bundle away the software layer.
|
| 43 |
SOUN
|
ai
automation
automotive
enterprise
software
|
SoundHound AI, Inc.
|
2.4x
|
0.40
|
Over five years, SoundHound can still compound if it moves from selling raw voice interactions to owning higher-value workflow decisions across voice and messaging, but the win condition is economic capture, not just more endpoints or more queries.
|
| 44 |
IONQ
|
cloud
defense
hardware
networking
quantum
|
IonQ, Inc.
|
2.4x
|
0.50
|
IonQ has a credible path to become a scarce quantum infrastructure platform rather than just a speculative science project, but shareholder returns from here depend on converting roadmap proof, SkyWater-enabled manufacturing control, and adjacent networking/security products into repeatable multi-year revenue faster than valuation compresses.
|
| 45 |
KTOS
|
aerospace
defense
hardware
software
space
|
Kratos Defense & Security Solutions, Inc.
|
2.4x
|
0.60
|
Kratos is a leveraged bet on affordable autonomous defense mass: if Valkyrie, engines, hypersonics and space-ground programs cross from development into funded production, revenue can more than double by 2031 and equity can compound at mid-teens rates even with some multiple normalization.
|
| 46 |
AMBA
|
ai
automotive
hardware
robotics
semiconductors
|
Ambarella, Inc.
|
2.4x
|
0.66
|
Ambarella is a real edge-AI silicon supplier with rising-content product cycles; if CV7, automotive, robotics, edge infrastructure, and channel/software layers convert design wins into production, revenue can roughly triple by 2031 even with only modest share gains, with the main limits being concentration, insourcing, and timing.
|
| 47 |
BBAI
|
ai
defense
enterprise
software
transportation
|
BigBear.ai Holdings, Inc.
|
2.4x
|
0.58
|
BigBear.ai can roughly double enterprise value by 2031 if Ask Sage and adjacent mission workflows shift it from a lumpy federal contractor into trusted secure AI software embedded in defense and trade workflows; if that mix shift fails, today's valuation is difficult to sustain.
|
| 48 |
APLD
|
ai
cloud
energy
hardware
|
Applied Digital Corporation
|
2.3x
|
0.68
|
Applied Digital can still more than double by 2031 if it converts scarce powered campuses and 1.2 GW of contracted capacity into operating rent faster than financing costs and dilution absorb the economics; the upside comes from power access and contract-backed scale, not software.
|
| 49 |
CORZ
|
ai
cloud
crypto
energy
|
Core Scientific, Inc.
|
2.3x
|
0.60
|
Core can roughly 2.5x enterprise value by 2031 if it proves it is a scarce time-to-power landlord rather than a cyclical miner: convert leased megawatts into billable AI colocation revenue, diversify beyond the anchor tenant, and use its campus footprint for faster expansion than greenfield rivals.
|
| 50 |
SNOW
|
ai
cloud
enterprise
software
|
Snowflake Inc.
|
2.3x
|
0.68
|
Snowflake should outgrow software-market norms if it becomes the governed runtime for enterprise data and AI workflows; usage growth, developer tooling, and trust-heavy execution surfaces can compound revenue, but hyperscaler dependence and open-stack competition likely cap upside to premium compounding rather than extreme rerating.
|
| 51 |
AVAV
|
aerospace
defense
robotics
software
space
|
AeroVironment, Inc.
|
2.3x
|
0.65
|
AeroVironment can roughly triple equity value by May 2031 if it converts backlog, Army program positions, and BlueHalo-expanded portfolio breadth into repeat production and higher-value integrated system sales; the upside comes from replenishment, interoperability, and better mix, not from pretending it is a pure software stock.
|
| 52 |
OKLO
|
ai
defense
energy
nuclear
|
Oklo Inc.
|
2.3x
|
0.70
|
Oklo is a high-beta option on AI-era power scarcity: if it converts regulatory progress, fuel access, and customer-backed site development into one operating proof point and an early repeatable campus rollout, revenue can inflect non-linearly by 2031, but today’s valuation already assumes meaningful success.
|
| 53 |
APP
|
advertising
ai
media
software
|
AppLovin Corporation
|
2.2x
|
0.60
|
AppLovin is a rare ad-tech compounder where AI directly improves the core product, but the equity case now depends on proving Axon can scale beyond gaming into broader commerce and CTV fast enough to outgrow inevitable multiple compression from an already premium starting point.
|
| 54 |
FIVN
|
ai
cloud
communications
enterprise
software
|
Five9, Inc.
|
2.2x
|
0.42
|
Five9 is an embedded enterprise workflow asset in a growing AI contact-center market; if it shifts value capture from human seats toward AI software, fixed commitments, and outcome-linked control points, revenue can roughly double and the stock can rerate from a depressed base without needing frontier-model leadership.
|
| 55 |
RIOT
|
ai
cloud
crypto
energy
hardware
|
Riot Platforms, Inc.
|
2.2x
|
0.58
|
Riot is a scarce-power optionality story: if it converts approved Texas megawatts into repeatable AI campus leases and funds most growth with tenant-backed or project capital rather than dilution, its revenue mix can shift from volatile mining toward contracted digital infrastructure and support a little over 2x equity value by 2031.
|
| 56 |
ALAB
|
ai
hardware
networking
semiconductors
software
|
Astera Labs, Inc.
|
2.2x
|
0.68
|
Astera can still grow well above semiconductor norms by expanding content per AI rack from retimers into switches, custom links, cables and a higher-value operations layer, but shareholder upside now depends on turning Scorpio qualification into broad multi-customer production before pricing and concentration compress the premium.
|
| 57 |
ASTS
|
communications
defense
hardware
networking
space
|
AST SpaceMobile, Inc.
|
2.1x
|
0.68
|
AST owns scarce spectrum access, carrier distribution, and direct-to-cell space hardware; if it clears the 2026-2027 launch and approval sequence, it can evolve from milestone revenue into a global reliability layer for mobile operators, but today’s valuation already assumes meaningful execution.
|
| 58 |
DDOG
|
ai
cloud
cybersecurity
enterprise
software
|
Datadog, Inc.
|
2.1x
|
0.60
|
Datadog should outgrow most software peers as AI makes software estates more complex, failure-prone, and security-sensitive; the real upside is moving from premium telemetry into trusted operational control, verification, and higher-value workflow monetization.
|
| 59 |
SMCI
|
ai
cloud
hardware
networking
software
|
Super Micro Computer, Inc.
|
2.1x
|
0.58
|
Supermicro is not the irreplaceable choke point in AI infrastructure, but its rack-scale speed, liquid-cooling integration, and rising software/service attach can still turn a bruised hardware valuation into a solid 5-year winner if cash conversion and compliance credibility normalize.
|
| 60 |
CRWV
|
ai
cloud
enterprise
hardware
software
|
CoreWeave, Inc.
|
2.1x
|
0.74
|
CoreWeave is one of the clearest public ways to own AI infrastructure scarcity, but the real five-year payoff comes from converting power, backlog, and structured finance into live high-utilization capacity while adding more inference and software attachment before raw compute pricing normalizes.
|
| 61 |
NTRA
|
ai
biotech
healthcare
|
Natera, Inc.
|
2.1x
|
0.62
|
Natera looks like a premium precision-diagnostics compounder: Signatera can keep expanding oncology revenue through evidence, reimbursement, and workflow embedment, while women’s health and organ health fund scale and optional higher-value data or enterprise layers. The stock can still work, but future returns depend more on execution and margin maturation than on another big rerating.
|
| 62 |
TWST
|
automation
biotech
healthcare
|
Twist Bioscience Corporation
|
2.1x
|
0.60
|
Twist is a picks-and-shovels biology platform that can turn AI-driven sequence demand into faster synthetic DNA output, broader workflow share, and better margins, but the equity only compounds meaningfully if manufacturing scale, NGS recovery, and workflow control translate into durable value capture before gene ordering becomes more price-transparent.
|
| 63 |
AMPX
|
aerospace
defense
energy
transportation
|
Amprius Technologies, Inc.
|
2.1x
|
0.58
|
Amprius is a real chemistry winner in weight-sensitive batteries, and if it converts deployed programs plus domestic trusted supply into repeat volume while moving some value capture above the cell, revenue can scale non-linearly even though the stock should de-rate from today’s premium hardware multiple.
|
| 64 |
CRNC
|
ai
automotive
enterprise
software
|
Cerence Inc.
|
2.1x
|
0.46
|
Cerence is a small-cap automotive AI tollbooth: if 2026 xUI launches convert into recurring connected and variable-license revenue while debt keeps falling, the market can rerate it from a noisy legacy voice supplier into a durable embedded auto software asset.
|
| 65 |
META
|
advertising
ai
communications
hardware
media
|
Meta Platforms, Inc.
|
2.0x
|
0.76
|
Meta is a rare mega-cap where AI is already improving the core cash engine rather than only funding future optionality: better ranking, targeting and measurement lift ad ROI now, while WhatsApp business agents, commerce workflows and trust products create additive capture. The realistic upside is a durable doubling by 2031, not hypergrowth, because compute and regulation absorb part of the gain.
|
| 66 |
CRDO
|
ai
cloud
hardware
networking
semiconductors
|
Credo Technology Group Holding Ltd
|
2.0x
|
0.60
|
Credo sits in a real AI bottleneck: reliable, low-power cluster connectivity. Over five years, the main upside is turning an AEC-led beachhead into broader optical, signal-processing and photonics content while preserving qualification-driven pricing power well enough to outrun multiple compression.
|
| 67 |
CRM
|
ai
automation
cloud
enterprise
software
|
Salesforce, Inc.
|
2.0x
|
0.60
|
Salesforce can roughly double enterprise value by May 2031 if it turns its large CRM and service installed base into a higher-value mix of AI, data, integration, and governed workflow revenue; the upside does not need a euphoric rerating, but it does require paid production usage to outgrow seat pressure and weakness in older clouds.
|
| 68 |
WULF
|
ai
cloud
crypto
energy
|
TeraWulf Inc.
|
2.0x
|
0.68
|
TeraWulf is a scarce-power developer being re-rated into AI infrastructure; the 5-year win condition is not more narrative, but converting contracted megawatts into energized, recurring cash flows faster than dilution and financing drag rise.
|
| 69 |
CLS
|
ai
cloud
communications
hardware
networking
|
Celestica Inc.
|
2.0x
|
0.62
|
Celestica is one of the few scaled operators turning AI cluster demand into shipped switches, racks and qualified capacity; if 2026-2027 capex converts into sticky higher-value programs and service attach, revenue can reach 31000 by 2031 and equity can roughly double without requiring a software-style rerating.
|
| 70 |
FN
|
automation
communications
hardware
networking
|
Fabrinet
|
2.0x
|
0.62
|
Fabrinet is a scarce, trusted manufacturing choke point for AI-era optical links; if it keeps converting qualification-heavy ramps into loaded Thailand capacity, revenue can more than double by 2031, though value capture will still resemble a premium industrial more than a software monopoly.
|
| 71 |
LSCC
|
ai
communications
hardware
networking
semiconductors
|
Lattice Semiconductor Corporation
|
2.0x
|
0.60
|
Lattice is well placed to own more of the low-power control, security, and manageability layer around AI racks and intelligent edge systems; if AMI closes and system-level attach expands, revenue can compound hard enough to overcome multiple compression and still roughly double enterprise value by 2031.
|
| 72 |
MSFT
|
ai
cloud
cybersecurity
enterprise
software
|
Microsoft Corporation
|
2.0x
|
0.86
|
Microsoft can still grow into a much larger company by monetizing AI at three layers at once—Azure capacity, enterprise control planes, and daily workflow surfaces—with additive upside if Copilot expands from seat attach into governed agent, workflow, and sovereign-capacity economics.
|
| 73 |
NET
|
ai
cloud
cybersecurity
networking
software
|
Cloudflare, Inc.
|
2.0x
|
0.67
|
Cloudflare can keep compounding by owning an inline internet control point where AI-era traffic, APIs, Zero Trust policy, and agent governance converge; the upside is strongest if it captures premium trust and verification spend, not just more raw edge usage.
|
| 74 |
RMBS
|
ai
cybersecurity
hardware
networking
semiconductors
|
Rambus Inc.
|
2.0x
|
0.64
|
Rambus is an asset-light owner of AI memory, interconnect, and silicon-trust bottlenecks; if it turns HBM, DDR5/SOCAMM2, PCIe and security design activity into sustained chip and IP revenue while holding royalty cash flows together, revenue can roughly triple by 2031 even as the valuation multiple normalizes.
|
| 75 |
AMZN
|
advertising
ai
cloud
enterprise
transportation
|
Amazon.com, Inc.
|
2.0x
|
0.84
|
Amazon can still nearly double by 2031 because AI makes scarce compute, trusted execution, and transaction rails more valuable, and Amazon already controls all three through AWS, embedded governance, and Prime fulfillment; the main debate is return on capex, not end-demand.
|
| 76 |
MRVL
|
ai
cloud
hardware
networking
semiconductors
|
Marvell Technology, Inc.
|
2.0x
|
0.65
|
Marvell can grow into a much larger AI infrastructure supplier as custom silicon, optical links and switch content expand across hyperscaler clusters, but the stock already discounts major success, so most 5-year upside must come from shipped revenue rather than multiple expansion.
|
| 77 |
PANW
|
ai
cloud
cybersecurity
enterprise
software
|
Palo Alto Networks, Inc.
|
2.0x
|
0.78
|
PANW should compound into a larger AI-era security control plane by 2031 as machine identities, agent workflows, and attack volume make its policy, telemetry, and response layers more valuable; CyberArk and observability deepen wallet share, but from a $200B base the realistic equity outcome is premium compounding rather than explosive rerating.
|
| 78 |
TSLA
|
ai
automotive
energy
robotics
transportation
|
Tesla, Inc.
|
2.0x
|
0.70
|
Tesla can still roughly double by 2031 if it converts its installed vehicle, charging and battery base into higher-margin software, energy, insurance and fleet revenue; the upside does not require a full robotaxi moonshot, but it does require regulatory progress, battery throughput and mix shift away from pure auto economics.
|
| 79 |
HUT
|
ai
cloud
crypto
energy
hardware
|
Hut 8 Corp.
|
1.9x
|
0.67
|
Hut 8's upside over the next five years comes from converting scarce power rights and site-development capability into contracted AI campus revenue, with equity value driven by whether River Bend and Beacon Point become repeatable, mostly project-financed templates rather than one-off wins.
|
| 80 |
SYM
|
ai
automation
enterprise
robotics
software
|
Symbotic Inc.
|
1.9x
|
0.66
|
Symbotic can still create roughly 2x enterprise value by 2031 if it converts its $22.7B remaining performance obligations into a much larger installed base and then layers higher-margin software, services, and trusted operating workflows onto each live site; the opportunity is real, but the premium valuation means diversification and clean execution matter as much as demand.
|
| 81 |
ORCL
|
ai
cloud
enterprise
healthcare
software
|
Oracle Corporation
|
1.9x
|
0.70
|
Oracle can still roughly double enterprise value by 2031 if it converts scarce powered OCI capacity into sustained cloud revenue while using its database and application footprint to pull through multicloud, automation, and governed AI execution; the upside comes from backlog conversion and new usage surfaces more than from a richer software multiple.
|
| 82 |
COHR
|
automation
communications
hardware
networking
semiconductors
|
Coherent Corp.
|
1.9x
|
0.74
|
Coherent owns scarce photonics process depth at an AI networking bottleneck; if it converts 6-inch indium phosphide capacity, broader optical content, and strategic supply agreements into shipped volume and mix, revenue can roughly double by 2031 even without a major valuation rerating.
|
| 83 |
SNPS
|
ai
enterprise
hardware
semiconductors
software
|
Synopsys, Inc.
|
1.9x
|
0.78
|
Synopsys should remain a premium compounder because AI increases the amount of chip, packaging, verification, and system-simulation work that must pass through trusted, foundry-qualified engineering flows; the upside is bigger wallet share across EDA, IP, verification, and simulation rather than a speculative rerating.
|
| 84 |
TSM
|
ai
automation
hardware
semiconductors
|
Taiwan Semiconductor Manufacturing Company Limited
|
1.9x
|
0.94
|
TSMC remains a premier Last Economy toll booth: cheaper cognition expands chip demand, while scarce leading-edge manufacturing and packaging let TSMC convert that demand into high-margin volume. The upside is meaningful, but it should come mainly from more capacity and richer mix, not from a dramatic rerating.
|
| 85 |
AMD
|
ai
cloud
enterprise
hardware
semiconductors
|
Advanced Micro Devices, Inc.
|
1.9x
|
0.72
|
AMD is one of the few scaled, credible alternatives in AI compute, and the next five years should bring major revenue expansion from EPYC share gains plus Instinct and Helios ramps; however, with the stock already pricing substantial success, most upside should come from execution-led growth rather than a dramatic re-rating.
|
| 86 |
AVGO
|
ai
cloud
networking
semiconductors
software
|
Broadcom Inc.
|
1.9x
|
0.80
|
Broadcom is one of the few mega-caps that still has non-linear upside because it sells scarce AI cluster content and a sticky private-cloud control layer; if it keeps premium economics with hyperscalers and turns software into a trust and governance layer, revenue can more than double even from today’s large base.
|
| 87 |
RGTI
|
cloud
hardware
quantum
semiconductors
|
Rigetti Computing, Inc.
|
1.9x
|
0.47
|
Rigetti owns a rare full-stack superconducting quantum asset base, so revenue can grow non-linearly from a tiny base if 108-qubit systems turn into repeatable sovereign installs, reserved capacity, and trusted workflow contracts; but from a $7B+ valuation, shareholders mostly win only if commercial proof arrives fast enough to outrun multiple compression.
|
| 88 |
ANET
|
ai
cloud
hardware
networking
software
|
Arista Networks, Inc.
|
1.9x
|
0.72
|
Arista is a high-quality AI networking toll collector: if it converts scarce Ethernet fabric demand into broader campus, routing, and control-layer software attachment, revenue can reach 30000 by 2031 and equity can roughly double even with some valuation compression.
|
| 89 |
SITM
|
ai
communications
hardware
networking
semiconductors
|
SiTime Corporation
|
1.9x
|
0.60
|
SiTime is a scarce pure-play on precision timing content rising inside AI, communications, and reliability-critical systems; if it closes and integrates the Renesas timing assets well, it can evolve from premium socket vendor into a broader timing franchise with enough revenue scale to roughly double enterprise value despite material multiple compression.
|
| 90 |
BKSY
|
ai
defense
software
space
|
BlackSky Technology Inc.
|
1.9x
|
0.70
|
BlackSky can still create attractive 5-year equity upside if Gen-3 turns recent wins into durable sovereign and defense subscriptions, but from today’s already-rich starting price the payoff now depends on executing a lower-dilution, higher-trust, more embedded capacity model rather than on another pure narrative rerating.
|
| 91 |
PLTR
|
ai
automation
defense
enterprise
software
|
Palantir Technologies Inc.
|
1.9x
|
0.78
|
Palantir can grow far faster than typical large software if it becomes the governed action layer for AI inside defense and regulated enterprises, but because the stock already discounts rare trust and execution, the realistic upside case is strong double-digit annual returns rather than another explosive rerating.
|
| 92 |
ARM
|
ai
cloud
hardware
semiconductors
software
|
Arm Holdings plc
|
1.9x
|
0.80
|
Arm is one of the few AI-era compute tollbooths: if it keeps lifting royalty dollars per design, expands in cloud and edge, and turns AGI CPU demand into real shipments without breaking ecosystem trust, revenue can scale hard by 2031. Shareholder upside is real but capped by an already extreme starting valuation.
|
| 93 |
JBL
|
ai
automation
cloud
hardware
networking
|
Jabil Inc.
|
1.9x
|
0.58
|
Jabil is a scarce physical way to own AI infrastructure buildout: if it turns qualified rack, power, cooling, and regulated manufacturing capacity into stickier programs with modestly better margins, equity value can roughly double by 2031 without needing a software-style valuation.
|
| 94 |
CDNS
|
ai
automation
cloud
semiconductors
software
|
Cadence Design Systems, Inc.
|
1.8x
|
0.74
|
Cadence should remain a premium AI-era workflow tollbooth: rising advanced-node, chiplet, verification, and system-simulation complexity can roughly double revenue by 2031, but today’s rich valuation likely caps equity upside to strong compounding rather than moonshot returns.
|
| 95 |
NTAP
|
ai
cloud
enterprise
hardware
software
|
NetApp, Inc.
|
1.8x
|
0.56
|
NetApp can compound faster than a typical storage vendor by using ONTAP switching friction, hyperscaler-native distribution, and cyber/AI data-management attach to improve revenue quality; the upside is a durable re-rating compounder, not a frontier-AI moonshot.
|
| 96 |
CBRS
|
ai
cloud
enterprise
hardware
semiconductors
|
Cerebras Systems Inc.
|
1.8x
|
0.74
|
Cerebras can grow revenue non-linearly as low-latency inference becomes valuable for agents and real-time AI, but equity upside depends on turning speed into contracted, diversified, high-utilization capacity before multiple compression outruns business growth.
|
| 97 |
NVDA
|
ai
hardware
networking
semiconductors
software
|
NVIDIA Corporation
|
1.8x
|
0.95
|
NVIDIA should remain the default AI infrastructure stack through 2031, letting revenue nearly double via accelerators, systems, networking and software attach, but from a multi-trillion-dollar base the stock is more likely to compound strongly than to repeat its last scarcity-driven rerating.
|
| 98 |
CRWD
|
ai
cloud
cybersecurity
enterprise
software
|
CrowdStrike Holdings, Inc.
|
1.8x
|
0.72
|
CrowdStrike should keep compounding as AI expands the attack surface and pushes enterprises toward fewer trusted security control planes, but the stock is already priced for exceptional execution so shareholder returns should lag the business’s revenue growth.
|
| 99 |
MPWR
|
ai
automotive
energy
hardware
semiconductors
|
Monolithic Power Systems, Inc.
|
1.8x
|
0.78
|
MPWR is a real AI-era power-density beneficiary: as AI servers, optical links, EVs and robots need more efficient power delivery, MPS can keep taking higher-content sockets and move from chip vendor to fuller power-solutions supplier, but with the stock already priced as elite quality, most upside must come from sustained revenue compounding rather than multiple expansion.
|
| 100 |
GOOG
|
advertising
ai
cloud
enterprise
media
|
Alphabet Inc.
|
1.8x
|
0.76
|
Alphabet should compound rather than moonshot: Search and YouTube still fund the machine, Cloud is becoming a second engine, and AI can add action, trust, and infrastructure layers on top of existing distribution. Upside is meaningful because Google can monetize AI across consumer intent, enterprise workflows, and compute, but size, capex, and remedies cap rerating.
|
| 101 |
AAOI
|
ai
communications
hardware
networking
semiconductors
|
Applied Optoelectronics, Inc.
|
1.7x
|
0.66
|
AAOI sits in a real AI bandwidth bottleneck and can grow revenue several-fold if it turns 800G and 1.6T qualifications into repeatable output, but because value capture still comes mainly from hardware margin and heavy reinvestment, the likely 5-year stock outcome is strong rather than explosive.
|
| 102 |
DELL
|
ai
cloud
enterprise
hardware
networking
|
Dell Technologies Inc.
|
1.7x
|
0.56
|
Dell is a strong AI infrastructure operator, not a monopoly: if it converts backlog into shipped systems and adds higher-value storage, cyber, automation and financing attach, equity can compound meaningfully even while the business remains hardware-led.
|
| 103 |
VRT
|
ai
automation
energy
hardware
networking
|
Vertiv Holdings Co.
|
1.7x
|
0.69
|
Vertiv is a scarce AI infrastructure supplier whose power, thermal, rack, and service content rises as compute density increases; the business can compound hard through 2031, but shareholder upside should come mainly from revenue scale and service depth rather than another major rerating from an already premium valuation.
|
| 104 |
VST
|
energy
nuclear
|
Vistra Corp.
|
1.7x
|
0.74
|
Vistra is a scarce-megawatt quality-upgrade story: existing nuclear and gas assets, longer-duration contracts, Cogentrix, and selective AI-linked site monetization can lift cash-flow quality faster than revenue, supporting a solid re-rating and equity compounding into 2031.
|
| 105 |
MTSI
|
communications
defense
networking
semiconductors
|
MACOM Technology Solutions Holdings, Inc.
|
1.7x
|
0.64
|
MACOM can grow well above semiconductor norms over the next five years because it sells physical bottlenecks in AI connectivity and trusted defense electronics, but the stock already carries a rich premium, so upside depends on proving durable value capture through qualification, supply assurance and subsystem-like attach rather than just shipping more parts.
|
| 106 |
VICR
|
ai
defense
energy
hardware
semiconductors
|
Vicor Corporation
|
1.7x
|
0.65
|
Vicor owns a real AI-era bottleneck in dense power delivery; if it converts backlog, expands CHiP output, and adds more licensing and subsystem capture, revenue can scale sharply by 2031, but today’s premium valuation means shareholder upside should be solid rather than explosive.
|
| 107 |
PL
|
aerospace
ai
defense
software
space
|
Planet Labs PBC
|
1.7x
|
0.62
|
Planet owns scarce daily Earth telemetry that becomes more valuable as AI makes interpretation cheap; over five years it can expand from imagery into sovereign capacity, tasking, verification, and embedded workflows, but because the stock already prices strategic scarcity, shareholder returns should be driven mainly by backlog conversion, Pelican execution, and proof of durable value capture above raw pixels.
|
| 108 |
STEM
|
automation
energy
enterprise
software
|
Stem, Inc.
|
1.7x
|
0.45
|
Stem’s upside is a distressed-equity rerating: if PowerTrack becomes an embedded control, compliance, and verification layer for clean-energy fleets instead of just a monitoring tool, modest revenue growth and a cleaner mix can create outsized equity gains from today’s tiny market cap.
|
| 109 |
TLN
|
ai
energy
nuclear
|
Talen Energy Corporation
|
1.7x
|
0.70
|
Talen can compound value by turning scarce PJM-connected megawatts into longer-duration AI-load and reliability cash flows; if Cornerstone closes and Susquehanna stays reliable, the market can increasingly value it as a contracted power platform rather than a purely merchant generator.
|
| 110 |
CEG
|
ai
energy
nuclear
|
Constellation Energy Corporation
|
1.6x
|
0.82
|
Constellation should outgrow normal utilities because AI, electrification and reshoring raise the value of scarce clean-firm power, licensed nuclear sites and power-ready campuses; the upside will come more from converting that scarcity into premium long-duration contracts and reliability products than from a dramatic rerating.
|
| 111 |
ETN
|
aerospace
automation
energy
hardware
software
|
Eaton Corporation plc
|
1.6x
|
0.68
|
Eaton should remain a strong AI-and-electrification picks-and-shovels compounder: scarce electrical capacity, deep channel trust and a broader power-plus-cooling stack can lift continuing revenue meaningfully by 2031, but the stock already reflects premium quality so returns should come mainly from execution and mix, not a huge rerating.
|
| 112 |
BWXT
|
aerospace
defense
energy
healthcare
nuclear
|
BWX Technologies, Inc.
|
1.6x
|
0.65
|
BWXT should keep compounding as a scarce owner of trusted nuclear throughput, cleared manufacturing and fuel-cycle know-how; AI-era power demand and defense fuel urgency expand demand, but shareholder returns are likely capped by a premium starting valuation and externally gated program timing.
|
| 113 |
MU
|
ai
enterprise
hardware
semiconductors
|
Micron Technology, Inc.
|
1.6x
|
0.78
|
Micron is one of the few public AI bottleneck assets in memory, but the equity case now depends less on proving demand and more on converting scarce HBM, server DRAM and SSD supply into durable, less-cyclical value capture before industry capacity catches up.
|
| 114 |
ON
|
ai
automotive
energy
hardware
semiconductors
|
ON Semiconductor Corporation
|
1.6x
|
0.72
|
onsemi owns qualified power and sensing sockets that benefit as AI racks, 900V vehicles, and electrified industrial systems demand more efficient silicon; if recent design wins lift fab loading and mix, revenue can rise sharply, but shareholder returns should be solid rather than explosive because much of the value still sits in a competitive component layer.
|
| 115 |
EQIX
|
ai
cloud
enterprise
networking
|
Equinix, Inc.
|
1.5x
|
0.78
|
EQIX is an AI-era toll booth: cheaper cognition increases the need for scarce powered metros, neutral interconnection and compliant traffic control, so revenue should compound well; however, shareholder upside is capped by power-constrained build cycles, REIT funding needs and an already premium starting valuation.
|
| 116 |
LITE
|
ai
cloud
hardware
networking
semiconductors
|
Lumentum Holdings Inc.
|
1.5x
|
0.62
|
Lumentum owns scarce, qualified optical hardware in the AI networking stack, so revenue can compound strongly as cluster bandwidth rises; but with the stock already priced as a bottleneck, shareholder returns depend on turning scarcity into durable qualification, broader customer depth, and sustained margins before industry capacity catches up.
|
| 117 |
ASML
|
ai
automation
hardware
semiconductors
software
|
ASML Holding N.V.
|
1.5x
|
0.88
|
ASML should keep compounding as the bottleneck owner of advanced chip patterning for the AI buildout, but the stock is more likely to deliver premium-quality compounding than nonlinear upside because export controls, supplier bottlenecks and a rich starting valuation cap the equity torque.
|
| 118 |
PWR
|
cloud
communications
energy
|
Quanta Services, Inc.
|
1.5x
|
0.65
|
Quanta should keep compounding as AI-driven load growth, grid hardening and generation buildouts increase demand for schedule-certain power infrastructure, but the stock’s five-year upside depends more on turning labor, trust and equipment access into better mix and premium contracts than on simple backlog growth.
|
| 119 |
NEE
|
ai
automation
energy
nuclear
|
NextEra Energy, Inc.
|
1.5x
|
0.78
|
NextEra owns scarce grid access and a top-tier power build engine just as AI, data centers and electrification make reliable delivered power the bottleneck; if it keeps converting that demand into approved rate base and long-term contracts, and closes Dominion on acceptable terms, it can keep compounding above utility peers without needing a dramatic rerating.
|
| 120 |
RKLB
|
aerospace
defense
hardware
space
|
Rocket Lab Corporation
|
1.5x
|
0.68
|
Rocket Lab can become a much larger space-and-defense prime by 2031 as Neutron, spacecraft manufacturing, payloads, and in-house components widen revenue per customer, but the stock already embeds a large share of that future, so strong operational growth likely translates into only moderate equity upside unless medium-lift launch and higher-trust recurring layers land on time.
|
| 121 |
HPE
|
ai
cloud
enterprise
hardware
networking
|
Hewlett Packard Enterprise Company
|
1.4x
|
0.60
|
HPE can turn AI-era infrastructure demand into strong shareholder compounding if Juniper makes networking the profit engine and GreenLake plus financing convert more AI box sales into stickier, better-quality cash flow.
|